| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/19/2007 | US20070087990 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection |
| 04/19/2007 | US20070087989 siRNA specific for myocilin and mutant myocilin; double stranded RNA; gene expression inhibition; for treatment of glaucoma |
| 04/19/2007 | US20070087987 Modulation of glucagon receptor expression |
| 04/19/2007 | US20070087984 Method of identifying agents that inhibit the growth of cancer cells |
| 04/19/2007 | US20070087982 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 04/19/2007 | US20070087438 Methods for conditioning plant somatic embryos |
| 04/19/2007 | US20070087437 Methods for rejuvenating cells in vitro and in vivo |
| 04/19/2007 | US20070087436 Microinjection method and device |
| 04/19/2007 | US20070087435 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 04/19/2007 | US20070087433 Adeno-associated viral vector for use as heterologous gene transfer agent |
| 04/19/2007 | US20070087432 Using the Wyeth smallpox vaccine in series to treat herpes infections |
| 04/19/2007 | US20070087427 Crystal structure of a deacetylase and inhibitors thereof |
| 04/19/2007 | US20070087426 Novel transferase and amylase, process for producing the enzymes, use thereof, and gene coding for the same |
| 04/19/2007 | US20070087425 Using modified saccharomyces as bioreactors for fermentation of farnesol, nerolidol and/or geranylgeraniol |
| 04/19/2007 | US20070087424 Methods and materials for the production of shikimic acid |
| 04/19/2007 | US20070087421 Transformant and process for producing polyester using the same |
| 04/19/2007 | US20070087420 Mortierella alpina C16/18 fatty acid elongase |
| 04/19/2007 | US20070087419 Method of producing biotin |
| 04/19/2007 | US20070087417 Multiplex polynucleotide synthesis |
| 04/19/2007 | US20070087416 Hyaluronan synthase gene and uses thereof |
| 04/19/2007 | US20070087412 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 04/19/2007 | US20070087410 Preparing heat resistant hydrolase in culture of genetically engineered aspergillus for use in food processing; animal husbandry |
| 04/19/2007 | US20070087408 Regulation of Toll-Like Receptors on Stem Cells |
| 04/19/2007 | US20070087407 Hepatitis C receptor protein CD81 |
| 04/19/2007 | US20070087403 Optimised micro-organism strains for nadph-consuming biosynthetic pathways |
| 04/19/2007 | US20070087398 Inactivated Enzyme Variants And Associated Process And Reagent System |
| 04/19/2007 | US20070087390 Opiate, cannabinoid, and estrogen receptors |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087385 Spherical and magnetical silicagel carriers having an increase surface for purifying nucleic acids |
| 04/19/2007 | US20070087381 Methods for constructing scdb libraries |
| 04/19/2007 | US20070087379 Nucleotide sequences coding protein for use in the treatment of blood disorders; cDNA derived from mouse yolk sacs |
| 04/19/2007 | US20070087374 Optimization of immunomodulatory properties of genetic vaccines |
| 04/19/2007 | US20070087373 Optimization of immunomodulatory properties of genetic vaccines |
| 04/19/2007 | US20070087372 Isolated ductal fluid sample |
| 04/19/2007 | US20070087371 Zinc finger domains and methods of identifying same |
| 04/19/2007 | US20070087362 Plurality of beads immobilized in a semi-solid medium to form an array; miniaturized, high density, clonal bead-based arrays; polymerase colony (polony) technology; hybridization, replication, genetic engineering |
| 04/19/2007 | US20070087361 Determining which allele is present in a sample tot reduce non-specific hybridization or reduce the impact of non-specific hybridization on the assay by using oligonucleotides having at least on non-standard base (iscytosine and isoguanine); kits |
| 04/19/2007 | US20070087351 Orotate transporter encoding maker genes |
| 04/19/2007 | US20070087349 Highly parallel template-based dna synthesizer |
| 04/19/2007 | US20070087347 Dose-dependent promoter originating in humans |
| 04/19/2007 | US20070087346 Orthogonal gene switches |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087335 Interference RNA for use in treatment and prevention of human immunodeficiency viral infection |
| 04/19/2007 | US20070087332 Pulmonary stem cells, related methods and kits of parts |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087045 Lipid carrier and method of preparing the same |
| 04/19/2007 | US20070087019 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/19/2007 | US20070087008 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 04/19/2007 | US20070087006 Compositions and methods for the diagnosis and treatment of tumor |
| 04/19/2007 | US20070086988 Reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, NAKT-13 |
| 04/19/2007 | US20070086985 Vectors for tissue-specific replication |
| 04/19/2007 | US20070086983 Endothelium-targeting nanoparticle for reversing endothelial dysfunction |
| 04/19/2007 | US20070086982 Gene therapy for regulating smooth muscle tone |
| 04/19/2007 | DE10248141B4 Nukleinsäuren und deren Verwendung für die Gentherapie Nucleic acids and their use for gene therapy |
| 04/19/2007 | DE10205091B4 Verfahren zur Vorhersage der Expressionseffizienz in zellfreien Expressionssystemen A method for predicting the expression efficiency in a cell-free expression systems |
| 04/19/2007 | DE102005049527A1 Verfahren zur Herstellung von L-Serin, Gensequenz, Vektoren sowie Mikroorganismus A process for preparing L-serine, gene sequence, vectors and microorganism |
| 04/19/2007 | DE102005049072A1 Astaxanthinbiosynthese in Eukaryoten Astaxanthinbiosynthese in eukaryotes |
| 04/19/2007 | DE102005048898A1 EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen EGLN2 variants and their use in the prevention or treatment of thromboembolic diseases and coronary heart disease |
| 04/19/2007 | DE102005048828A1 New light, oxygen, voltage domains, and proteins containing them, useful as fluorescent markers, e.g. in gene therapy, cloning and cell sorting, are altered to prevent covalent bonding to flavine mononucleotide |
| 04/19/2007 | CA2639119A1 Agent for preventing/treating cancer |
| 04/19/2007 | CA2625731A1 Human microrna targets in hiv genome and a method of identification thereof |
| 04/19/2007 | CA2625492A1 Yeast and method of producing l-lactic acid |
| 04/19/2007 | CA2625488A1 Methods and compositions for treating immune disorders |
| 04/19/2007 | CA2625440A1 Compositions comprising cross-species-specific antibodies and uses thereof |
| 04/19/2007 | CA2625352A1 Method of producing recombinant protein |
| 04/19/2007 | CA2625350A1 Polynucleotides encoding phenylpropanoid pathway enzymes in coffee |
| 04/19/2007 | CA2625349A1 Methods and compositions relating to anthrax spore glycoproteins as vaccines |
| 04/19/2007 | CA2625193A1 Reconstructed living adipose tissue |
| 04/19/2007 | CA2624781A1 Nanobodies tm and polypeptides against egfr and igf-ir |
| 04/19/2007 | CA2624673A1 Allele-specific rna interference |
| 04/19/2007 | CA2624615A1 Compositions and methods for treatment of autoimmune disease |
| 04/19/2007 | CA2624531A1 Wwox gene, vectors containing the same, and uses in treatment of cancer |
| 04/19/2007 | CA2623687A1 Nucleic acids encoding modified cytochrome p450 enzymes and methods of use thereof |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2622894A1 New esterases and their use for processes for kinetic resolution of butinolesters |
| 04/19/2007 | CA2621214A1 Process for the production of arachidonic acid and/or eicosapentaenoic acid |
| 04/19/2007 | CA2609116A1 Animal model of schizophrenia |
| 04/19/2007 | CA2595171A1 Transgenic plants with enhanced agronomic traits |
| 04/19/2007 | CA2590399A1 Methods and compositions for detecting bacillus anthracis |
| 04/19/2007 | CA2587510A1 Recombinant influenza vectors with tandem transcription units |
| 04/18/2007 | EP1775346A1 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
| 04/18/2007 | EP1775345A2 Vector constructors |
| 04/18/2007 | EP1775344A2 Lipase, its gene, the strain and the application of this lipase |
| 04/18/2007 | EP1775343A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 04/18/2007 | EP1775342A1 Anticancer agent containing minus-strand rna virus |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1774977A2 Genetically engineered bleb vaccine |
| 04/18/2007 | EP1774962A1 Lipid carrier and method of preparing the same |
| 04/18/2007 | EP1774959A1 Double stranded RNA oligonucleotide to inhibit tyrosinase expression |
| 04/18/2007 | EP1774332A2 Immune response assessment method |
| 04/18/2007 | EP1774317A1 IMMUNE-COMPROMISED TRANSGENIC MICE EXPRESSING HUMAN HEPATOCYTE GROWTH FACTOR (hHGF) |
| 04/18/2007 | EP1774036A2 Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles |
| 04/18/2007 | EP1774033A2 Multiplexing assays for analyte detection |
| 04/18/2007 | EP1774032A2 Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same |
| 04/18/2007 | EP1774031A2 Cancer treatment method by inhibiting mage gene expression or function |
| 04/18/2007 | EP1774020A2 Phage microarray profiling of the humoral response to disease |
| 04/18/2007 | EP1774019A2 Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| 04/18/2007 | EP1774018A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 04/18/2007 | EP1774016A2 Methods for expressing rnp particles in eukaryotic cells |
| 04/18/2007 | EP1774008A2 Inducible gene expression |